111 related articles for article (PubMed ID: 8615669)
41. Successful treatment of human immunodeficiency virus-related Castleman's disease: a case report and literature review.
Liberopoulos E; Tolis C; Bai M; Efremidis S; Pavlidis N; Elisaf M
Oncology; 2003; 65(2):182-6. PubMed ID: 12931026
[TBL] [Abstract][Full Text] [Related]
42. [Pseudo-myelomatous plasmacytosis of the bone marrow in a multicentric Castleman's disease].
Molina T; Brouland JP; Bigorgne C; Le Tourneau A; Delmer A; Audouin J; Diebold J
Ann Pathol; 1996; 16(2):133-6. PubMed ID: 8767683
[TBL] [Abstract][Full Text] [Related]
43. A rare case of Castleman's disease of plasma cell type within kidney.
Zhu YC; Huang Y; Yao J; Li X; Zhao S; Wei Q; Zeng H
Chin Med J (Engl); 2009 Oct; 122(19):2396-8. PubMed ID: 20079147
[No Abstract] [Full Text] [Related]
44. Pathologic quiz case 2. Giant lymph node hyperplasia (Castleman's disease), hyaline vascular type.
Allcroft RA
Arch Otolaryngol Head Neck Surg; 1986 Apr; 112(4):450-1, 453. PubMed ID: 3947465
[No Abstract] [Full Text] [Related]
45. Castleman's disease presenting as prolonged anemia and growth retardation: a case report and literature review.
Yang M; Wang FD; Han B; Wang SJ; Zhou DB; Pan H; Zhao YQ; Cui QC; Ma L; Chng WJ; Shen T
Acta Haematol; 2011; 125(3):125-9. PubMed ID: 21150179
[No Abstract] [Full Text] [Related]
46. Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndrome.
Jain P; Verstovsek S; Loghavi S; Jorgensen JL; Patel KP; Estrov Z; Fayad L; Pemmaraju N
Am J Hematol; 2015 Nov; 90(11):1091-2. PubMed ID: 25808231
[No Abstract] [Full Text] [Related]
47. Retinoic acid for treatment of multicentric Castleman's disease.
Rieu P; Droz D; Gessain A; Grünfeld JP; Hermine O
Lancet; 1999 Oct; 354(9186):1262-3. PubMed ID: 10520638
[TBL] [Abstract][Full Text] [Related]
48. [Polyclonal plasmacytosis in peripheral blood and leukocytoclastic vasculitis in Castleman's disease].
Izutsu K; Usuki K; Inoue K; Endo M; Iki S; Matsuya S; Urabe A
Rinsho Ketsueki; 1998 Mar; 39(3):210-5. PubMed ID: 9577645
[TBL] [Abstract][Full Text] [Related]
49. [Effect of cimetidine on the course of measles].
Tuncer AM; Teczan I; Dağli E; Kinik E
Mikrobiyol Bul; 1985 Jan; 19(1):1-8. PubMed ID: 2858811
[TBL] [Abstract][Full Text] [Related]
50. Absence of gallium uptake in multicentric Castleman's disease of plasma cell type.
Chim CS; Choi FP; Ooi GC; Kwong YL
Haematologica; 2001 Apr; 86(4):442-3. PubMed ID: 11325657
[TBL] [Abstract][Full Text] [Related]
51. [Report of two cases of Castleman's disease and the related literature review].
Ge JH; Li JL; Liu S
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Mar; 45(3):250-1. PubMed ID: 20450712
[No Abstract] [Full Text] [Related]
52. [Retrospective study of multicentric Castleman's disease treated with CEOD chemotherapy].
Wang HH; Yao K; Li YC
Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):56-8. PubMed ID: 22575196
[No Abstract] [Full Text] [Related]
53. [Castleman's disease, plasma cell type, mesenteric, with important systemic impact].
Marigil Gómez MA; Zornoza Celaya G; Gómez Portilla A; Aguirre de Santiago MA
Med Clin (Barc); 1985 Oct; 85(11):476. PubMed ID: 4068821
[No Abstract] [Full Text] [Related]
54. [Benign mediastinal opacity: Castleman disease, apropos of a case and review of the current literature].
Cuguilliére A; Lonjon T; Ortega O; Fourcade L; Eeskandari J; Branquet D; Cador L; Bonnet D
Rev Pneumol Clin; 1997; 53(1):21-6. PubMed ID: 9181148
[TBL] [Abstract][Full Text] [Related]
55. [H2 receptor antagonist treatment and stomach cancer].
Amland PF; Svane S
Tidsskr Nor Laegeforen; 1987 Apr; 107(12):1023. PubMed ID: 2885944
[No Abstract] [Full Text] [Related]
56. Gallium scintigraphy in the diagnosis and management of multifocal Castleman's disease.
Stansby G; Hilson A; Hamilton G
Br J Radiol; 1991 Feb; 64(758):165-7. PubMed ID: 2004209
[No Abstract] [Full Text] [Related]
57. [Description of a rare case of Castleman's lymphoma. Critical review of the literature].
Storella D; Di Nanni N
Minerva Chir; 1989 Oct; 44(19):2119-22. PubMed ID: 2694017
[TBL] [Abstract][Full Text] [Related]
58. Mixed variant multicentric Castleman disease treated with rituximab: case report.
Mian H; Leber B
J Pediatr Hematol Oncol; 2010 Nov; 32(8):622. PubMed ID: 20921905
[No Abstract] [Full Text] [Related]
59. Recalcitrant Grysbovski's keratoacanthomas with good response to cimetidine.
Baican A; Norris DA; Birlea SA
Am J Med; 2010 Apr; 123(4):e9-10. PubMed ID: 20362743
[No Abstract] [Full Text] [Related]
60. [Castleman's disease: the problems of diagnosis and treatment].
Sukhodolia AI; Chubar IV; Sukhodolia SA; Hryshchuk OV
Klin Khir; 2012 Jul; (7):63-4. PubMed ID: 23033784
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
